Cytotoxicity

“Bugs Delivering Drugs” – Researchers Publish New Approach To Colorectal Cancer Treatment Using Common Food-Borne Bacteria

by

Baylor University researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S. VanNieuwenhze, PhD, FRSC, University Distinguished Professor and chair of the Department of Biology, along with Baylor doctoral students and a colleague at Texas Tech University Health Sciences … Read more

New rifamycin drugs fight antibiotic-resistant lung infections more effectively

by

Modified antibiotics beat a stubborn lung pathogen and dodge metabolic landmines, offering new hope for patients with HIV, cystic fibrosis, and TB co-infections. Study: Next-generation rifamycins for the treatment of mycobacterial infections. Image Credit: Kateryna Kon / Shutterstock The rise of drug-resistant bacteria is a major health crisis. Moreover, the development of antibiotic resistance in pulmonary pathogens … Read more

Neoantigen vaccine sparks powerful immune defense against kidney cancer

by

A groundbreaking clinical trial shows how a personalized cancer vaccine primes the immune system to target kidney cancer, preventing recurrence and offering new hope for patients with high-risk disease. Study: A neoantigen vaccine generates antitumour immunity in renal cell carcinoma. Image Credit: crystal light / Shutterstock In a recent study published in the journal Nature, researchers demonstrated … Read more